Nouvelles
Découvrez les dernières nouvelles et les développements en IA et en apprentissage automatique dans le domaine de la thérapie guidée par imagerie (TGI) au Canada.
INOVAIT publishes health data licensing tools to unlock Canadian health data for innovation
The Data Licensing Toolkit supports Canadian healthcare institutions in establishing governance processes for responsible and trustworthy sharing of de-identified health data with industry and other partners.
Pionnier de l’imagerie médicale: Terry Peters
Comment 16 Bit a mis à profit l’IA pour prévenir les fractures coûteuses, une radiographie à la fois
As with many transformative businesses, 16 Bit came to be because of, sure, the brilliance and vision of its founders, but also a great deal of serendipity. 16 Bit might not exist had Dr. Mark Cicero and Dr. Alexander Bilbily not both chosen to pursue medical school (with backgrounds in engineering and computer science, respectively), had they not both decided to specialize in radiology, and had they not ended up in the same residency training program at the University of Toronto.
Nouvelles du réseau
PulseMedica is laser-focused on tackling vitreoretinal diseases
The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.
Sonic Incytes is making liver screening more accessible
Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).
Le fonds Pilote d’INOVAIT accepte maintenant les candidatures pour des projets de thérapie guidée par imagerie
October 18, 2023 | Toronto, ON – INOVAIT, the pan-Canadian network for image-guided therapy (IGT), is now accepting...
Travailler dans le secteur IGT au Canada : les entreprises IGT embauchent dès maintenant
Les entreprises membres d'INOVAIT recherchent des talents qui pourraient contribuer à transformer la prestation des soins de santé. Serait-ce vous ?...
Série de conférences sur la TGI
Regulating AI in Image-Guided Therapy
Suivre INOVAIT sur les médias sociaux
Le Réseau dans la presse
